New
CT

CARTemis Therapeutics

The AI engine Fit Assessment

Beta

The company will attend Deep Tech Momentum 2026

Blurb

Provider of engineered cellular therapies intended for the treatment of blood cancers and autoimmune disorders. The company offers engineered CAR T cells targeting and a microRNA-based amplifier, enabling clinical researchers and oncologists to explore more precise and effective cancer treatment options.

HQ Location

Berlin (Germany)

Founded

2023

Employees

Not available

Total funding raised

Not available

Funding Status

Not available

Provider of engineered cellular therapies intended for the treatment of blood cancers and autoimmune disorders. The company offers engineered CAR T cells targeting and a microRNA-based amplifier, enabling clinical researchers and oncologists to explore more precise and effective cancer treatment options.